AzTrials
AzTrials

Inactivity, PhysicalNCT07429370

The Effects of One Day of Activity on the Next Day's Exercise Response

A study testing Decreased step count in people with Inactivity, Physical, run by Concordia University Wisconsin at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Exercise can reduce the risk of several chronic diseases. However, recent studies have suggested sitting for too long before exercising can decrease exercise benefits. This study will help determine why this may occur. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Inactivity, Physical
What is being tested?
Decreased step count
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteUnited States
Study dates
1 Jan 2026to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • • between the ages of 18-30 years old

Who cannot join

  • • free from acute or chronic illness (cardiac, pulmonary, liver, or kidney abnormalities, cancer, uncontrolled hypertension, insulin- or non-insulin dependent diabetes or other known metabolic disorders)
  • do not take medications related to metabolism (i.e., statins, metformin, GLP-1 agonists)
  • free from orthopedic limitations (including any artificial joints)
  • currently smoke or participate in other forms of tobacco use.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kevin J Gries, PhD contact

2622434293

kevin.gries@cuw.edu

United States1 site, 1 recruiting
  • Concordia University of Wisconsin

    Mequon, Wisconsin, 53093

    Kevin J Gries, PhD, 2622434293, kevin.gries@cuw.edu

    Recruiting

Other trials in United States

About this study

Official title: A Single Day of Inactivity on the Systemic Metabolic and Inflammatory Exercise Response

Exercise can reduce the risk of several chronic diseases. However, recent studies have suggested sitting for too long before exercising can decrease exercise benefits. This study will help determine why this may occur.

Read the detailed description

Previous work demonstrated a greater utilization of carbohydrates (CHO) at the end of aerobic exercise with a day of reduced activity (<5,000 steps). Additionally, there are differences in the RNA profile at rest and during exercise in pathways related to inflammation, metabolism, and innate immunity that warrant further research. Together, these data highlight that a single day of reduced activity alters systemic homeostasis that affects the exercise response. Given the potency of exercise to ameliorate risk of cardiovascular disease, more research is needed to find factors to augment the exercise response. Therefore, this study has two goals: 1) Analyze circulating metabolomics, and 2) metabolomics and proteomics in response to exercise after a day of reduced activity.

Being tested
Decreased step count
Keywords
Exercise, Metabolism
Medical subject headings
Sedentary Behavior, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Decreased step countBehavioural

    Subjects will walk less than 5,000 steps

Study groups in NCT07429370
Study groupRoleWhat they receive
>8,500 steps the day prior to exericseActive comparatorNot described
Receives: Behavioral: Decreased step count
<5,000 steps the day prior to exerciseExperimentalNot described
Receives: Behavioral: Decreased step count

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Concentration of metabolites within the plasma

    We will collect blood before and immediately after exercise. Plasma will be separated and sent for untargeted metabolomic analysis.

    Measured: Participants will complete the study within 6 weeks of enrollment.

  2. Concentration of proteins within the plasma

    We will collect blood before and immediately after exercise. Plasma will be separated and sent for untargeted proteomic analysis.

    Measured: Participants will complete the study within 6 weeks of enrollment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2026
  2. Study start1 Jan 2026
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
6 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07429370
Sponsor's protocol ID
https://pubmed.ncbi.nlm.nih.go
Other IDs
26BAIREA1560979
Status last verified
Feb 2026
First submitted
17 Feb 2026
Last updated
24 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Decreased step count in people with Inactivity, Physical, run by Concordia University Wisconsin at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kevin J Gries, PhD (2622434293, kevin.gries@cuw.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Concentration of metabolites within the plasma (time frame: Participants will complete the study within 6 weeks of enrollment.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in